Metraipolis › archive › dc_8bfe46170b2f

Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK) — Europe PMC PMID:42263913

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42263913
DOI
10.1016/j.virusres.2026.199759
License (as archived)
solo-consultazione
Archived
2026-10-31T15:36:36.316Z
SHA-256 of the archived text
5b258f47c629c6f4c9e9fba66c6ccd9bd82b7fa96a3f3d759f31170c5d45bbc8
Stable URL of this page
https://metraipolis.com/documento/dc_8bfe46170b2f

How to cite

Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK) — Europe PMC PMID:42263913 — Europe PMC (en), https://europepmc.org/article/MED/42263913 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8bfe46170b2f (Metraipolis archive dc_8bfe46170b2f, sha256 5b258f47c629c6f4c9e9fba66c6ccd9bd82b7fa96a3f3d759f31170c5d45bbc8)
BibTeX
@misc{dc8bfe46170b2f,
  title = {Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK) — Europe PMC PMID:42263913},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42263913},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8bfe46170b2f; sha256 5b258f47c629c6f4c9e9fba66c6ccd9bd82b7fa96a3f3d759f31170c5d45bbc8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42263913. Agents can read the archived copy with the MCP tool read_document.